These findings suggest that in chemoresistant gastric cancer cells, JMJD3 not only enhances stemness but also sensitizes cells to ferroptosis, providing a potential therapeutic strategy to improve treatment efficacy. This evidence concerns the gene KDM6B and gastric cancer.